Sebi plans to expand scope of UPSI

In a move that could increase disclosures from listed companies, the Securities and Exchange Board of India (Sebi) has proposed sweeping additions to the definition of unpublished price sensitive information (UPSI). The additions include credit rating changes, fundraising proposals, restructuring plans and defaults.

The regulator has outlined 13 proposals to broaden the scope of events that could affect stock prices such as resignation of auditor, change in key managerial personnel other than superannuation or end of term, major agreements affecting company control, fraud by a listed company or arrests of its key members.

This move comes after a study by Sebi showed that listed companies only disclosed material events to the stock exchanges that were explicitly mentioned in the insider trading regulations, and “not complying with the spirit of law”.

“Sebi felt that there exists a need to review the definition of UPSI to bring about regulatory clarity, certainty and uniformity in compliance for the listed companies,” the regulator said in a draft paper, inviting comments by November 30.

Developments in corporate insolvency cases and forensic audits —particularly if they uncover fund misappropriation or financial misstatements — have also been suggested for disclosure as price-sensitive events.

Orders passed by any regulatory or judicial bodies against a company or its key members, as well as the outcome of any litigation or dispute might also be considered sensitive information. Giving of guarantees or indemnity for any third party has also been suggested for inclusion.

Further, the granting, withdrawal or suspension of essential licences or approvals should be disclosed, the regulator proposed, as such events could significantly impact company operations. The termination or receival of any order not in ordinary course of business might also be included in the definition.

The regulator said the working group has “strived to ensure that its recommendations do not adversely impact the ease of doing business or significantly increase the compliance requirement of listed entities”.

 » Read More

Related Articles

Mphasis posts modest revenue, profit growth in Q3

Mphasis reported a sequential revenue growth of 0.8% to Rs 3,561.3 crore and a net profit of Rs 427.9 crore, up 1.1%, for the quarter ended December.  “We continue to stay focused on driving deal activity and closures, as we get on the other side of the macro cycle. AI is driving a fundamental shift

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Mphasis posts modest revenue, profit growth in Q3

Mphasis reported a sequential revenue growth of 0.8% to Rs 3,561.3 crore and a net profit of Rs 427.9 crore, up 1.1%, for the quarter ended December.  “We continue to stay focused on driving deal activity and closures, as we get on the other side of the macro cycle. AI is driving a fundamental shift

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of